Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In the world economic growth, the Rabies Vaccine industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Rabies Vaccine market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Rabies Vaccine market size will be further expanded, we expect that by 2024, The market size of the Rabies Vaccine will reach XXX million $.
Overview:
Rabies is a vaccine-preventable disease, and it is the most cost-effective strategy for preventing rabies in people. Rabies vaccine is an active immunizing agent that is used to prevent infection caused by the rabies virus. Rabies is a viral zoonotic disease caused through a dog’s bite which leads to progressive and fatal inflammation of the brain and spinal cord. There are a number of rabies vaccines available that are both safe and effective. Rabies vaccine is an immunization used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. Human rabies vaccines undergo a series of quality control tests such as safety, potency, toxicity, and sterility. The rabies vaccine works remarkably well. Studies indicate that if the vaccine is given immediately and appropriately to someone who was bitten by a rabid animal, it is 100 percent effective.
Market Drivers:
Increasing prevalence of rabies and growing burden of mortality due to rabies around the world is expected to boost growth of the global rabies vaccine market over the forecast period. Rabies is a vaccine-preventable viral disease which occurs in more than 150 countries and territories. For instance, according to the World Health Organization (WHO), every year, over 29 million people worldwide receive a post-bite vaccination. Hence, such factors are expected to drive growth of the global rabies vaccine market during the forecast period.
Moreover, large population of stray dogs in low and middle income countries and growing pet management technological advancements and services are expected to augment growth of the global rabies vaccine market over the forecast period.
Market Restraints:
Low immunization rates in dogs and lack of awareness and negligence by public is expected to hamper the growth of the global rabies vaccine market over the forecast period.
Regional Insights:
Among regions, North America and Asia Pacific are expected to witness substantial growth in the global rabies vaccine market owing to the rising government initiatives, increasing number of human deaths attributed to rabies, and introduction of new rabies vaccine in the region. For instance, in September 2021, on the occasion of World Rabies Day, the Government of India launched a national action plan NAPRE for the elimination of dog mediated rabies by 2030.
Competitive Section:
Major companies involved in the global rabies vaccine market are GSK (Novartis), Hissen, BCHT, Changsheng, VACN, Prcmise, Yisheng, Chengda, and Sanofi-Pasteur, among others.
For instance, November 2019, in November 2019, Chiron Behring Vaccines re-launched the well-established and trusted purified chick embryo cell vaccine manufactured at its WHO pre-qualified facility in Ankleshwar, Gujarat as Chirorab.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Industry Segmentation
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
